DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $49,525,000 | -26.8% | 2,456,595 | +35.5% | 9.00% | -48.8% |
| Q2 2021 | $67,676,000 | +55.2% | 1,813,392 | +6.3% | 17.58% | +123.1% |
| Q1 2021 | $43,607,000 | +46.0% | 1,705,392 | +25.8% | 7.88% | +27.0% |
| Q4 2020 | $29,859,000 | +20.7% | 1,355,392 | -1.4% | 6.21% | +137.1% |
| Q3 2020 | $24,732,000 | -33.1% | 1,374,776 | -5.5% | 2.62% | -64.9% |
| Q2 2020 | $36,949,000 | +62.5% | 1,454,686 | +17.6% | 7.45% | -15.9% |
| Q1 2020 | $22,731,000 | +67.9% | 1,237,379 | +101.4% | 8.86% | +74.3% |
| Q4 2019 | $13,536,000 | – | 614,436 | – | 5.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |